Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth

The chemokine receptor, CXCR4 signaling regulates cell growth, invasion, and metastasis to the bone-marrow niche in prostate cancer (PCa). Previously, we established that CXCR4 interacts with phosphatidylinositol 4-kinase IIIα (PI4KIIIα encoded by PI4KA) through its adaptor proteins and PI4KA overexpressed in the PCa metastasis. To further characterize how the CXCR4-PI4KIIIα axis promotes PCa metastasis, here we identify CXCR4 binds to PI4KIIIα adaptor proteins TTC7 and this interaction induce plasma membrane PI4P production in prostate cancer cells. Inhibiting PI4KIIIα or TTC7 reduces plasma membrane PI4P production, cellular invasion, and bone tumor growth. Using metastatic biopsy sequencing, we found PI4KA expression in tumors correlated with overall survival and contributes to immunosuppressive bone tumor microenvironment through preferentially enriching non-activated and immunosuppressive macrophage populations. Altogether we have characterized the chemokine signaling axis through CXCR4-PI4KIIIα interaction contributing to the growth of prostate cancer bone metastasis.

[1]  Hong Liang,et al.  Components of the phosphatidylserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer. , 2021, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Hancock,et al.  Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity , 2021, Nature Communications.

[3]  L. Fong,et al.  How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer , 2021, Prostate Cancer and Prostatic Diseases.

[4]  Ash A. Alizadeh,et al.  Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx. , 2020, Methods in molecular biology.

[5]  Ash A. Alizadeh,et al.  Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.

[6]  A. Shisheva,et al.  A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells. , 2018, Oncogene.

[7]  E. Heath,et al.  Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis , 2016, Molecular Cancer.

[8]  P. De Camilli,et al.  The leukodystrophy protein FAM126A/Hyccin regulates PI4P synthesis at the plasma membrane , 2015, Nature Cell Biology.

[9]  I. Keklikoglou,et al.  Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. , 2015, Cancer research.

[10]  T. Balla,et al.  EFR3s are palmitoylated plasma membrane proteins that control responsiveness to G-protein-coupled receptors , 2015, Journal of Cell Science.

[11]  H. Weng,et al.  CXCR4 over-expression and survival in cancer: A system review and meta-analysis , 2014, Oncotarget.

[12]  T. Balla,et al.  A novel probe for phosphatidylinositol 4-phosphate reveals multiple pools beyond the Golgi , 2014, The Journal of cell biology.

[13]  G. Wang,et al.  SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial–mesenchymal transition via ERK and PI3K/AKT pathway , 2014, Medical Oncology.

[14]  Sang Yoon Lee,et al.  PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity , 2012, The Journal of cell biology.

[15]  P. Rolland,et al.  The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer , 2012, British Journal of Cancer.

[16]  T. Sparwasser,et al.  Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer , 2012, Oncoimmunology.

[17]  K. Pienta,et al.  Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. , 2011, The Journal of clinical investigation.

[18]  S. Sánchez-Ramón,et al.  The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. , 2011, Blood.

[19]  S. Sheng,et al.  Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells. , 2010, Translational oncology.

[20]  S. Jee,et al.  Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway. , 2009, Carcinogenesis.

[21]  S. Emr,et al.  Assembly of the PtdIns 4-kinase Stt4 complex at the plasma membrane requires Ypp1 and Efr3 , 2008, The Journal of cell biology.

[22]  Liang Zhao,et al.  Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway , 2008, British Journal of Cancer.

[23]  T. Kume,et al.  Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. , 2008, Biochemical and biophysical research communications.

[24]  M. Cher,et al.  CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone , 2008, Molecular Cancer Research.

[25]  D. Carbone,et al.  Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.

[26]  K. Shokat,et al.  Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIalpha. , 2007, Molecular biology of the cell.

[27]  Stephen L. Abrams,et al.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. , 2007, Biochimica et biophysica acta.

[28]  M. Ratajczak,et al.  The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis , 2006, Leukemia.

[29]  T. Balla,et al.  Phosphatidylinositol 4-kinases: old enzymes with emerging functions. , 2006, Trends in cell biology.

[30]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[31]  D. Jonas,et al.  CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. , 2006, Neoplasia.

[32]  Xiyun Deng,et al.  CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: The role of bone microenvironment‐associated CXCL12 , 2006, The Prostate.

[33]  A. Abdel‐Mageed,et al.  Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. , 2005, Cancer research.

[34]  P. Várnai,et al.  A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1. , 2005, Molecular biology of the cell.